Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**8-Bromo-Adenosine‑5′‑Monophosphate** is a synthetic brominated analogue of adenosine monophosphate (AMP), classified as a purine ribonucleoside monophosphate. It is primarily used in research as a molecular probe and tool compound for receptor mapping studies and to investigate nucleotide signaling pathways. The presence of the bromine atom at the C8 position alters its biochemical properties compared to natural AMP. While it can mimic some actions of endogenous AMP in biological systems, it is not approved for therapeutic use and has no established clinical indications. Its mechanism involves acting as an AMP analog; however, specific protein or receptor targets are not well characterized in the literature[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 8-bromo-adenosine-5'-monophosphate.